Circulation Research, Vol 62, 905-915, Copyright © 1988 by American Heart Association

ARTICLES

Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation

DR Morel, E Lowenstein, T Nguyenduy, DR Robinson, JE Repine, DE Chenoweth and WM Zapol
Department of Anesthesia, Massachusetts General Hospital, Boston 02114.

When protamine (2 mg/kg) was injected intravenously into awake sheep 5 minutes after infusing heparin (200 units/kg), there was transient diffuse pulmonary vasoconstriction with mean pulmonary arterial pressure increasing from 18.0 +/- 0.7 to 43.8 +/- 2.7 mm Hg at 1 minute (x +/- SEM; n = 10). In addition, there was profound leukopenia (36.9 +/- 7.7% of baseline values at 2 minutes) with transpulmonary leukocyte sequestration and transiently elevated plasma concentrations of C3a (from 420 +/- 146 to 1,599 +/- 249 ng/ml; n = 3, p less than 0.01) and thromboxane B2 (from 0.30 +/- 0.05 to 6.3 +/- 2.8 ng/ml; n = 10, p less than 0.0001), without significant increases of plasma 6-keto- prostaglandin F1 alpha, prostaglandin F2 alpha, leukotrienes, or histamine. Intravenous injection of protamine alone produced no hemodynamic effects and did not increase plasma levels of vasoconstrictor eicosanoids. Intravenous pretreatment with either a cyclooxygenase inhibitor or a hydrogen peroxide scavenger (dimethylthiourea) blocked both the increases of thromboxane levels and the pulmonary vasoconstriction.

This article has been cited by other articles:

				O. Shigeta, H. Kojima, Y. Hiramatsu, T. Jikuya, Y. Terada, N. Atsumi, Y. Sakakibara, T. Nagasawa, and T. Mitsui LOW-DOSE PROTAMINE BASED ON HEPARIN-PROTAMINE TITRATION METHOD REDUCES PLATELET DYSFUNCTION AFTER CARDIOPULMONARY BYPASS J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 354 - 360. [Abstract] [Full Text] [PDF]

				F. E. Ralley The Use of Nitric Oxide for Managing Catastrophic Pulmonary Vasoconstriction Arising from Protamine Administration Anesth. Analg., March 1, 1999; 88(3): 505 - 505. [Full Text] [PDF]

				H. Habazettl, V. Martinek, B. Vollmar, and P. Conzen ENHANCEMENT OF THE LEUKOCYTE-ENDOTHELIAL CELL INTERACTION IN COLLECTING VENULES OF SKELETAL MUSCLE BY PROTAMINE J. Thorac. Cardiovasc. Surg., April 1, 1997; 113(4): 784 - 791. [Abstract] [Full Text]

				R. B. Hird, T. W. Wakefield, R. Mukherjee, B. U. Jones, F. A. Crawford, P. C. Andrews, J. C. Stanley, and F. G. Spinale Direct Effects of Protamine Sulfate on Myocyte Contractile Processes : Cellular and Molecular Mechanisms Circulation, November 1, 1995; 92(9): 433 - 446. [Abstract] [Full Text]

				G. J. Dehmer, M. Fisher, D. A. Tate, S. Teo, and E. M. Bonnem Reversal of Heparin Anticoagulation by Recombinant Platelet Factor 4 in Humans Circulation, April 15, 1995; 91(8): 2188 - 2194. [Abstract] [Full Text]

				M. Friedman, R. G. Johnson, S. Y. Wang, H. B. Dai, R. L. Thurer, R. M. Weintraub, and F. W. Sellke Pulmonary microvascular responses to protamine and histamineEffects of cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1092 - 1099. [Abstract] [Full Text]

				R. D. Williams, M. N. D'Ambra, T. E. Maione, K. E. Lynch, and D. F. Keene Recombinant platelet factor 4 reversal of heparin in human cardiopulmonary bypass blood J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 975 - 983. [Abstract] [Full Text]

				D. S. Kucukaksu, S. F. Katircioglu, G. Saydam, M. Bozdayi, B. Mavitas, O. Tasdemir, and K. Bayazit Beneficial Effects of Prostacyclin on Pulmonary Function During Heparin Reversal with Protamine Vascular and Endovascular Surgery, May 1, 1993; 27(4): 264 - 267. [Abstract] [PDF]